CH588505A5 - - Google Patents

Info

Publication number: CH588505A5
Authority: CH; Switzerland

Application number

CH799973A

Original Assignee

Research Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-06-08

Filing date

1973-06-04

Publication date

1977-06-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22991508&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CH588505(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1973-06-04 Application filed by Research Corp filed Critical Research Corp

1977-06-15 Publication of CH588505A5 publication Critical patent/CH588505A5/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CH799973A 1972-06-08 1973-06-04 CH588505A5 (cs)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US26098972A	1972-06-08	1972-06-08

Publications (1)

Publication Number	Publication Date
CH588505A5 true CH588505A5 (cs)	1977-06-15

Family

ID=22991508

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
CH203677A CH605550A5 (cs)	1972-06-08	1973-06-04
CH799973A CH588505A5 (cs)	1972-06-08	1973-06-04

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
CH203677A CH605550A5 (cs)	1972-06-08	1973-06-04

Country Status (9)

Country	Link
US (1)	US4140707A (cs)
JP (1)	JPS5629676B2 (cs)
CA (1)	CA1023759A (cs)
CH (2)	CH605550A5 (cs)
DE (1)	DE2329485C3 (cs)
FR (1)	FR2187345B1 (cs)
GB (1)	GB1380228A (cs)
NL (2)	NL183724C (cs)
SE (2)	SE415182B (cs)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4258051A (en) *	1975-01-10	1981-03-24	Research Corporation	Method of treating viral infections
JPS6041077B2 (ja) *	1976-09-06	1985-09-13	喜徳喜谷	１，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
US4440782A (en) *	1977-03-01	1984-04-03	Research Corporation	Method of treating viral infections
US4225529A (en) *	1977-10-19	1980-09-30	Johnson, Matthey & Co., Limited	Compositions containing platinum
US4230631A (en) *	1977-10-19	1980-10-28	Johnson, Matthey & Co., Limited	Platinum coordination compounds
DE2845371A1 (de) *	1977-10-19	1979-04-26	Johnson Matthey Co Ltd	Platinkomplexverbindung, pharmazeutische stoffzusammensetzung mit einer solchen verbindung und deren anwendung
SE7903359L (sv) *	1978-04-20	1979-10-21	Johnson Matthey Co Ltd	Kompositioner innehallande platina
GB2019405A (en) *	1978-04-20	1979-10-31	Johnson Matthey & Co Ltd Pt	Pt (II) and (IV) Amino-Acid Complexes
SE7903361L (sv) *	1978-04-20	1979-10-21	Johnson Matthey Co Ltd	Kompositioner innehallande platina
NL7807334A (nl) *	1978-07-06	1980-01-08	Tno	Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een genees- middel met toepassing van een dergelijk platina-dia- minecomplex voor de behandeling van kanker, alsmede al- dus verkregen gevormd geneesmiddel.
JPS6034958B2 (ja) *	1978-09-02	1985-08-12	喜徳喜谷	新規白金錯体
US4234500A (en) *	1979-03-07	1980-11-18	Engelhard Minerals & Chemicals Corporation	Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
US4291027A (en) *	1979-03-07	1981-09-22	Engelhard Minerals & Chemicals Corp.	Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes
US4462998A (en) *	1979-06-20	1984-07-31	Engelhard Corporation	Method of using a cis-platinum(II) amine ascorbate
US4457926A (en) *	1979-06-20	1984-07-03	Engelhard Corporation	Cis-Platinum(II) amine ascorbate complexes
US4271085A (en) *	1979-06-20	1981-06-02	Engelhard Minerals & Chemicals Corporation	Cis-platinum (II) amine lactate complexes
US4505928A (en) *	1979-06-20	1985-03-19	Engelhard Corporation	Pharmaceutical composition containing cis-platinum (II) amine lactate and a method of using same
US4284579A (en) *	1979-07-17	1981-08-18	The United States Of America As Represented By The Of The Department Of Health & Human Services	(N-Phosphonacetyl-L-aspartato)(1,2-diaminocyclchexane)platinum(II) or alkali metal salt
US4329299A (en) *	1979-08-23	1982-05-11	Johnson, Matthey & Co., Limited	Composition of matter containing platinum
NL181434C (nl) *	1980-01-03	1987-08-17	Tno	Platina(iv)-diamine-complexen, alsmede hun bereiding en toepassing.
GR75598B (cs) *	1980-04-29	1984-08-01	Sanofi Sa
JPS56154493A (en) *	1980-04-30	1981-11-30	Shionogi & Co Ltd	Novel platinum complex
AU538863B2 (en) *	1980-05-27	1984-08-30	Bristol-Myers Company	Platinum complex salts have anti-tumor property
US4322362A (en) *	1980-07-28	1982-03-30	Bristol-Myers Company	Salts of 2-hydroxymalonate platinum complexes
US4428943A (en)	1980-06-09	1984-01-31	The United States Of America As Represented By The Department Of Health And Human Services	(N-Phosphonacetyl-L-aspartato) (1,2-diaminocyclohexane)platinum(II) or alkali metal salt
JPS5851959B2 (ja) *	1980-06-11	1983-11-19	呉羽化学工業株式会社	プラチナ化合物とその医薬組成物
JPS5716895A (en) *	1980-07-05	1982-01-28	Otsuka Chem Co Ltd	Platinum 2 complex and antitumor agent containing the same as active principle
JPS57123198A (en) *	1981-01-23	1982-07-31	Shionogi & Co Ltd	Novel platinum complex
JPS5896024A (ja) *	1981-10-16	1983-06-07	リチヤ−ド・エフ・ストツケル	白金毒解毒剤
US4500465A (en) *	1982-06-28	1985-02-19	Engelhard Corporation	Solubilized platinum (II) complexes
US4584392A (en) *	1982-11-10	1986-04-22	Inco Alloys International, Inc.	Platinum and palladium complexes
US4560782A (en) *	1982-11-19	1985-12-24	Research Corporation	Anti-tumor diplatinum coordination compounds
IL67789A (en) *	1983-01-31	1986-09-30	Yissum Res Dev Co	Amino-substituted malonato platinum(ii)complexes and method for their preparation
US4533502A (en) *	1983-02-22	1985-08-06	Rochon Fernande D	Platinum (II) compounds and their preparation
US4906646A (en) *	1983-03-31	1990-03-06	Board Of Governors Of Wayne State University	Method and composition for the treatment of tumors by administering a platinum coordination compound and a calcium channel blocker compound of the dihydropyridine class
US4617189A (en) *	1983-04-14	1986-10-14	Stockel Richard F	Use of selenium-containing compounds for negating the toxic effects of platinum compounds used in chemotherapy, and a novel selenium-containing platinum compound and use thereof as an anti-cancer medicine
JPS59222498A (ja) *	1983-06-01	1984-12-14	Shionogi & Co Ltd	新規グリコ−ル酸系白金錯体および抗悪性腫瘍剤
US4661516A (en) *	1983-06-20	1987-04-28	Research Corporation	Diaminocyclohexane platinum complexes
EP0130482B1 (en) *	1983-06-20	1988-12-28	Research Corporation	Diaminocyclohexane platinum complexes, process for preparing same and pharmaceutical compositions containing same
US4758588A (en) *	1983-06-20	1988-07-19	Research Corporation Technologies	Diaminocyclohexane platinum complexes
DE3477788D1 (en) *	1983-08-05	1989-05-24	Yoshinori Kidani	Cytostatic platinum complexes
GB8328218D0 (en) *	1983-10-21	1983-11-23	Johnson Matthey Plc	Oral compositions
JPS61500909A (ja) *	1984-01-23	1986-05-08	インスチツ−ト　オブスチエイ　イ　ネオルガニチエスコイ　ヒミイ　イメ−ニ　エヌ．エス．クルナコワ　アカデミ−　ナウク　エスエスエスエル	混合カルボキシラト白金（２）錯体類およびその製法
US4843161A (en) *	1984-06-01	1989-06-27	Massachusetts Institute Of Technology	Platinum-intercalative complexes for the treatment of cancer
GB8416048D0 (en) *	1984-06-22	1984-07-25	Johnson Matthey Plc	Anti-tumour compounds of platinum
EP0169645A1 (en) *	1984-06-27	1986-01-29	Johnson Matthey Public Limited Company	Platinum co-ordination compounds
US4645661A (en) *	1984-06-29	1987-02-24	St. Jude Children's Research Hospital	Method for alleviating cisplatin-induced nephrotoxicity and dithiocarbamate compounds for effecting same
US4696918A (en) *	1984-11-02	1987-09-29	Johnson Matthey Public Limited Company	Solubilized platinum compound
US4588831A (en) *	1984-11-09	1986-05-13	Natec	Platinum complex compounds of substituted 5,8-dihydroxyl-1,4-naphthoquinone, and process for their production and use
US4665210A (en) *	1984-12-17	1987-05-12	American Cyanamid Company	Platinum complexes of aliphatic tricarboxylic acids
ZA86704B (en) *	1985-02-23	1986-10-29	Asta Werke Ag Chem Fab	Tumor retarding(1-benzyl-ethylenediamine9-platin(ii)-complexes
CA1274529A (en) *	1985-09-05	1990-09-25	Federico Sampedro	Platinum(ii) complexes of 1,1-cyclobutane- dicarboxylate and process for their production
US4658047A (en) *	1985-09-27	1987-04-14	The United States Of America As Represented By The Department Of Health And Human Services	Method of preparing 1,2-diaminocyclohexane tetrachloro platinum (IV) isomers
US5384127A (en) *	1985-10-18	1995-01-24	Board Of Regents, The University Of Texas System	Stable liposomal formulations of lipophilic platinum compounds
US5117022A (en) *	1985-10-18	1992-05-26	The Board Of Regents, The University Of Texas System	Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5041581A (en) *	1985-10-18	1991-08-20	The University Of Texas System Board Of Regents	Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US4670458A (en) *	1986-01-31	1987-06-02	American Cyanamid Company	Hydroxylated 1,2-diaminocyclohexane platinum complexes
US4760157A (en) *	1986-01-31	1988-07-26	American Cyanamid Company	(2,2,-bis(aminomethyl)-1,3-propanediol-N,N')platinum complexes
CS269719B1 (en) *	1986-12-29	1990-05-14	Kiss Frantisek	Platinum cytostatic
US5041578A (en) *	1988-11-22	1991-08-20	Board Of Regents, The University Of Texas System	Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
US5434256A (en) *	1988-11-22	1995-07-18	Board Of Regents, The University Of Texas System	Diamine platinum complexes as antitumor agents
US5393909A (en) *	1988-11-22	1995-02-28	Board Of Regents, The University Of Texas System	Diamine platinum complexes as antitumor agents
US6884418B1 (en)	1989-08-04	2005-04-26	Berlex Laboratories, Inc.	Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy
US5455270A (en) *	1993-08-11	1995-10-03	Bristol-Myers Squibb Co.	Stabilized solutions of platinum(II) antitumor agents
WO1995020956A1 (en) *	1994-02-07	1995-08-10	Kiss Laboratories S.R.O.	Anti-tumour medical preparation on the basis of carboplatin and the method of its production
US5922689A (en) *	1995-09-11	1999-07-13	Unitech Pharmaceuticals, Inc.	Cisplatin analogs for cancer treatment
JP3154399B2 (ja) *	1996-07-04	2001-04-09	デビオファームエス．アー．	白金化合物の製造方法
US20040072889A1 (en) *	1997-04-21	2004-04-15	Pharmacia Corporation	Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
CN1068002C (zh) *	1997-04-30	2001-07-04	中国科学院大连化学物理研究所	铂抗癌药物及合成
CA2326761C (en) *	1998-04-03	2008-02-19	Ajinomoto Co., Inc.	Antitumor agent
US6858598B1 (en)	1998-12-23	2005-02-22	G. D. Searle & Co.	Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en)	1998-12-23	2004-12-21	G.D. Searle & Co.	Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
EP1229934B1 (en)	1999-10-01	2014-03-05	Immunogen, Inc.	Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
WO2001036431A1 (en)	1999-11-15	2001-05-25	Parker Hughes Institute	Diamino platinum (ii) antitumor complexes
US6545010B2 (en) *	2000-03-17	2003-04-08	Aventis Pharma S.A.	Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer
US7053065B2 (en) *	2000-06-30	2006-05-30	Eli Lilly And Company	Vitamin B12 and pemetrexed disodium combination therapies
DE10032256C2 (de) *	2000-07-03	2003-06-05	Infineon Technologies Ag	Chip-ID-Register-Anordnung
TWI315982B (en)	2001-07-19	2009-10-21	Novartis Ag	Combinations comprising epothilones and pharmaceutical uses thereof
JP2005508323A (ja) *	2001-09-26	2005-03-31	インターミューンインコーポレイテッド	癌治療のための医薬組成物及び方法
AU2003251955A1 (en) *	2002-07-16	2004-02-02	Sonus Pharmaceuticals, Inc.	Platinum compound
US7160908B2 (en) *	2003-03-04	2007-01-09	Unitech Pharmaceuticals, Inc.	Dynamic anticancer platinum compounds
US7129368B2 (en) *	2004-03-15	2006-10-31	Sonus Pharmaceuticals, Inc.	Platinum carboxylate anticancer compounds
AU2006207321B2 (en)	2005-01-21	2012-09-06	Astex Therapeutics Limited	Pharmaceutical compounds
ATE430564T1 (de) *	2005-03-28	2009-05-15	Dabur Pharma Ltd	Stabile pharmazeutische zusammensetzungen aus antitumoralen platin-(ii)-mitteln
EP2026800A1 (en)	2006-05-09	2009-02-25	Novartis AG	Combination comprising an iron chelator and an anti-neoplastic agent and use thereof
JP5528807B2 (ja)	2006-10-12	2014-06-25	アステックス、セラピューティックス、リミテッド	複合薬剤
JP5528806B2 (ja)	2006-10-12	2014-06-25	アステックス、セラピューティックス、リミテッド	複合薬剤
CA2667019C (en) *	2006-10-27	2016-03-29	Genentech, Inc.	Antibodies and immunoconjugates and uses therefor
CN101918030B (zh)	2007-11-09	2015-10-14	派瑞格恩医药公司	抗vegf抗体的组合物和方法
RU2510272C2 (ru)	2008-03-18	2014-03-27	Дженентек, Инк.	Комбинации конъюгата анти-her2-антитело-лекарственное средство и химиотерапевтических средств и способы применения
WO2009119092A1 (ja)	2008-03-27	2009-10-01	大鵬薬品工業株式会社	シチジン誘導体及びカルボプラチンを含有する抗腫瘍剤
JP4664424B2 (ja) *	2008-09-03	2011-04-06	ユニーテック株式会社	白金錯体及びそれを含む医薬組成物
WO2010104035A1 (ja)	2009-03-12	2010-09-16	学校法人近畿大学	非小細胞肺癌に対する化学療法の治療効果予測方法
BR112013025353A8 (pt)	2011-04-01	2018-01-02	Genentech Inc	combinação de a) um composto de fórmula ia, composto de fórmula ia ou um sal farmaceuticamente aceitável do mesmo, método para tratamento de um distúrbio hiperproliferativo em um mamífero, uso de um composto de fórmula ia ou um sal farmaceuticamente aceitável do mesmo, kit e produto
EP2508525A1 (en)	2011-04-05	2012-10-10	Bayer Pharma Aktiengesellschaft	Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts
JP5179628B2 (ja)	2011-07-15	2013-04-10	ユニーテック株式会社	４価白金錯体及びそれを含む医薬組成物
SG10201706196XA (en)	2012-06-08	2017-08-30	Hoffmann La Roche	Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
EP3386997B1 (en)	2015-12-09	2021-06-30	Medizinische Universität Wien	Monomaleimide-functionalized platinum compounds for cancer therapy
US10987353B2 (en)	2016-05-04	2021-04-27	The Wistar Institute Of Anatomy And Biology	Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and platinum-based antineoplastic drugs
CN107773556B (zh) *	2016-08-26	2020-08-18	广州安好医药科技有限公司	一种具有抗肿瘤药物功效的联合用药物
ES2955852T3 (es)	2017-04-03	2023-12-07	Hoffmann La Roche	Anticuerpos de unión a STEAP-1

1973
- 1973-06-04 CH CH203677A patent/CH605550A5/xx not_active IP Right Cessation
- 1973-06-04 CH CH799973A patent/CH588505A5/xx not_active IP Right Cessation
- 1973-06-05 CA CA173,182A patent/CA1023759A/en not_active Expired
- 1973-06-06 NL NLAANVRAGE7307863,A patent/NL183724C/xx active Protection Beyond IP Right Term
- 1973-06-07 GB GB2730473A patent/GB1380228A/en not_active Expired
- 1973-06-07 SE SE7308050A patent/SE415182B/xx active Protection Beyond IP Right Term
- 1973-06-07 FR FR7320788A patent/FR2187345B1/fr not_active Expired
- 1973-06-08 JP JP6463673A patent/JPS5629676B2/ja not_active Expired
- 1973-06-08 DE DE2329485A patent/DE2329485C3/de not_active Expired
1977
- 1977-03-18 US US05/778,955 patent/US4140707A/en not_active Expired - Lifetime
1978
- 1978-10-10 SE SE7810577A patent/SE7810577L/xx unknown
1993
- 1993-06-03 NL NL930049C patent/NL930049I2/nl unknown

Also Published As

Publication number	Publication date
DE2329485A1 (de)	1973-12-20
JPS4948621A (cs)	1974-05-11
US4140707B1 (cs)	1989-12-19
FR2187345A1 (cs)	1974-01-18
CA1023759A (en)	1978-01-03
GB1380228A (en)	1975-01-08
NL930049I1 (nl)	1993-09-01
FR2187345B1 (cs)	1976-12-31
CH605550A5 (cs)	1978-09-29
SE7810577L (sv)	1978-10-10
SE415182B (sv)	1980-09-15
US4140707A (en)	1979-02-20
NL183724B (nl)	1988-08-01
JPS5629676B2 (cs)	1981-07-09
DE2329485B2 (de)	1979-11-22
DE2329485C3 (de)	1980-07-31
NL7307863A (cs)	1973-12-11
NL930049I2 (nl)	1993-11-16
NL183724C (nl)	1989-01-02

Publication	Publication Date	Title
US4140707B1 (cs)	1989-12-19
FR2203208B1 (cs)	1976-10-01
FR2189375A1 (cs)	1974-01-25
JPS5320342B2 (cs)	1978-06-26
JPS5630849B2 (cs)	1981-07-17
FR2190712B1 (cs)	1977-02-18
JPS5222251B2 (cs)	1977-06-16
JPS523875B2 (cs)	1977-01-31
JPS534609B2 (cs)	1978-02-18
JPS5129589B2 (cs)	1976-08-26
JPS5221321Y2 (cs)	1977-05-16
JPS4937041U (cs)	1974-04-02
JPS49101451A (cs)	1974-09-25
JPS4891635A (cs)	1973-11-28
JPS521528Y2 (cs)	1977-01-14
FR2124746A5 (cs)	1972-09-22
JPS5311496Y2 (cs)	1978-03-28
JPS499148A (cs)	1974-01-26
JPS499105U (cs)	1974-01-25
CH580548A5 (cs)	1976-10-15
CH569848A5 (cs)	1975-11-28
CH575741A5 (cs)	1976-05-31
CH577950A5 (cs)	1976-07-30
CH579151A5 (cs)	1976-08-31
CH605761A5 (cs)	1978-10-13

Legal Events

Date	Code	Title	Description
1993-08-31	PL	Patent ceased
1995-09-29	SPCF	Supplementary protection certificate filed	Free format text: OICM 47671A, 950901
1996-02-29	SPCG	Supplementary protection certificate granted	Free format text: OICM 47671/860826, 950901, EXPIRES:19980603
1996-06-14	SPCF	Supplementary protection certificate filed	Free format text: OICM 47671/860826, 950901
1996-06-14	SPCG	Supplementary protection certificate granted	Free format text: OICM 47671/860826, 950901, EXPIRES:19980603
2001-10-31	SPCM	Certificates - modification of assignment	Free format text: RESEARCH CORPORATION 405 LEXINGTON AVENUE NEW YORK/NY (US)TRANSFER-RESEARCH CORPORATION TECHNOLOGIES, INC. 101 NORTH WILMOT ROAD, SUITE 600 TUCSON, ARIZONA 85711-3335 (US)
2024-10-31	PL	Patent ceased